NM_207034.3:c.277C>G

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5

The NM_207034.3(EDN3):​c.277C>G​(p.Arg93Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

EDN3
NM_207034.3 missense

Scores

10
5
4

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 1.02

Publications

3 publications found
Variant links:
Genes affected
EDN3 (HGNC:3178): (endothelin 3) The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Altered expression of this gene is implicated in tumorigenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
EDN3 Gene-Disease associations (from GenCC):
  • Waardenburg syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Waardenburg syndrome type 4B
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, PanelApp Australia, G2P
  • Waardenburg-Shah syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease, susceptibility to, 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_207034.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.944
PP5
Variant 20-59301634-C-G is Pathogenic according to our data. Variant chr20-59301634-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 16651.Status of the report is no_assertion_criteria_provided, 0 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EDN3NM_207034.3 linkc.277C>G p.Arg93Gly missense_variant Exon 2 of 5 ENST00000337938.7 NP_996917.1 P14138-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EDN3ENST00000337938.7 linkc.277C>G p.Arg93Gly missense_variant Exon 2 of 5 1 NM_207034.3 ENSP00000337128.2 P14138-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461852
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111992
Other (OTH)
AF:
0.00
AC:
0
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Waardenburg syndrome type 4B Pathogenic:1
Jul 01, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Pathogenic
0.38
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.89
D;.;D;.;D;.
Eigen
Uncertain
0.24
Eigen_PC
Benign
0.095
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.83
.;T;T;T;T;T
M_CAP
Pathogenic
0.38
D
MetaRNN
Pathogenic
0.94
D;D;D;D;D;D
MetaSVM
Uncertain
0.38
D
MutationAssessor
Uncertain
2.4
M;M;M;.;.;M
PhyloP100
1.0
PrimateAI
Uncertain
0.49
T
PROVEAN
Pathogenic
-6.8
D;D;D;.;D;D
REVEL
Pathogenic
0.72
Sift
Pathogenic
0.0
D;D;D;.;D;D
Sift4G
Pathogenic
0.0
D;D;D;.;D;D
Polyphen
1.0
D;.;D;.;D;D
Vest4
0.83
MutPred
0.73
Gain of catalytic residue at P89 (P = 0.0776);Gain of catalytic residue at P89 (P = 0.0776);Gain of catalytic residue at P89 (P = 0.0776);Gain of catalytic residue at P89 (P = 0.0776);Gain of catalytic residue at P89 (P = 0.0776);Gain of catalytic residue at P89 (P = 0.0776);
MVP
0.91
MPC
0.69
ClinPred
0.97
D
GERP RS
2.4
PromoterAI
0.0059
Neutral
Varity_R
0.88
gMVP
0.86
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267606779; hg19: chr20-57876689; API